Daniel K Spiegelman's Net Worth

$38.7 Million

Estimate Recalculated May 31, 2025 01:59AM EST

Who is Daniel K Spiegelman

Daniel K Spiegelman has an estimated net worth of $38.7 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Relypsa Inc, BIOMARIN PHARMACEUTICAL INC, OMEROS CORP, MYRIAD GENETICS INC, XCYTE THERAPIES INC, SPRUCE BIOSCIENCES, INC., Jiya Acquisition Corp., AFFYMAX INC, Anthera Pharmaceuticals Inc, CV THERAPEUTICS INC, Kyverna Therapeutics, Inc., and vTv Therapeutics Inc..

SEC CIK

Daniel K Spiegelman's CIK is 0001238403

Past Insider Trading and Trends

2013 was Daniel K Spiegelman's most active year for acquiring shares with 18 total transactions. Daniel K Spiegelman's most active month to acquire stocks was the month of May. 2016 was Daniel K Spiegelman's most active year for disposing of shares, totalling 19 transactions. Daniel K Spiegelman's most active month to dispose stocks was the month of May. 2015 saw Daniel K Spiegelman paying a total of $4,023,129.30 for 196,048 shares, this is the most they've acquired in one year. In 2015 Daniel K Spiegelman cashed out on 208,287 shares for a total of $14,479,760.44, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cascadian Therapeutics, Inc.

Investor

Updated Mar 13, 2018


Form 4	-100.00%	-34.93K	—	—	Mar 13, 2018	—	Disposition	—	Mar 09
Form 4	-2.75%	-594.00	$3.94	-$2.34K	Sep 26, 2017	21.01K	Options	—	Sep 24
Form 4	-10.54%	-2.27K	$3.78	-$8.56K	Jun 27, 2017	19.23K	Options	—	Jun 24
Form 4	103.25%	13.39K	$3.34	-$1.79K	Jun 13, 2017	26.36K	Options	—	Jun 09 - Jun 12
Form 4	—	54.35K	—	—	Jun 28, 2016	54.35K	Grant	—	Jun 24
Form 4	—	14.24K	—	—	Sep 28, 2015	14.25K	Grant	—	Sep 24
Form 4	15.66%	8.88K	$3.88	-$15.56K	Jun 16, 2015	65.56K	Options	—	Jun 12 - Jun 13
Form 4/A	96.88%	20.00K	$1.61	$32.13K	Apr 02, 2015	40.64K	Purchase	—	Mar 25 - Mar 26
Form 4	96.88%	20.00K	$1.61	$32.13K	Apr 01, 2015	40.64K	Purchase	—	Mar 25 - Mar 26
Form 4	-43.94%	-16.18K	$1.91	-$30.91K	Oct 08, 2014	20.64K	Sale	—	Feb 20 - Jul 10
Form 4	36.78%	14.29K	$3.06	-$6.25K	Jun 10, 2014	53.17K	Grant	—	Jun 06 - Jun 07
Form 4	-11.07%	-4.84K	$3.65	-$17.66K	Mar 12, 2014	38.87K	Options	—	Mar 11
Form 4	—	16.04K	—	—	Jun 14, 2013	16.04K	Grant	—	Jun 13
Form 4	-4.45%	-1.14K	$1.86	-$2.11K	Jun 11, 2013	24.36K	Tax	—	Jun 09
Form 4	47.20%	8.17K	$3.67	$30.00K	Jun 08, 2012	25.49K	Grant	—	Jun 07
Form 4	-10.45%	-2.02K	$3.51	-$7.09K	Jun 05, 2012	17.32K	Tax	—	Jun 03
Form 4	-7.40%	-1.55K	$6.86	-$10.61K	Dec 07, 2011	19.34K	Tax	—	Dec 04
Form 4	27.76%	4.54K	—	—	Jun 13, 2011	20.89K	Options	—	Jun 09 - Jun 12
Form 4	130.74%	8.09K	—	—	Jun 04, 2010	14.27K	Grant	—	Jun 03
Form 4	—	6.18K	—	—	Dec 07, 2009	6.19K	Grant	—	Dec 04
Form 4	—	2.08K	—	—	Jun 15, 2009	2.08K	Grant	—	Jun 12
Form 4/A	—	19.35K	—	—	Apr 21, 2009	19.35K	Grant	—	Mar 11
Form 4	—	21.43K	—	—	Mar 11, 2009	21.43K	Grant	—	Mar 11
Form 3	—	—	—	—	Jun 11, 2008	—	—	—	—

Showing 24 results

Relypsa Inc

Investor

Updated Sep 02, 2016


Form 4	-100.00%	-24.49K	$32.00	-$111.58K	Sep 02, 2016	—	Disposition	—	Sep 01
Form 4	545.68%	6.75K	—	—	Jun 23, 2016	7.99K	Grant	—	Jun 21
Form 4	-45.02%	-1.01K	$19.31	-$19.56K	Jun 08, 2016	1.24K	Sale	—	Jun 07
Form 4	—	6.75K	—	—	Jun 08, 2015	6.75K	Grant	—	Jun 04
Form 4	—	12.00K	—	—	Jun 23, 2014	12.00K	Grant	—	Jun 19
Form 3	—	—	—	—	Jun 23, 2014	—	—	—	—

Showing 6 results

BIOMARIN PHARMACEUTICAL INC

EVP, Chief Financial Officer

Updated Jun 07, 2019

View Quote Details


Form 4	0.37%	176.00	$68.78	$12.11K	Jun 07, 2019	47.69K	Grant	—	Apr 30
Form 4	-22.09%	-13.47K	$89.00	-$1.20M	Apr 03, 2019	47.51K	Sale	Scheduled	Apr 01
Form 4	-0.16%	-100.00	$90.00	-$9.00K	Mar 29, 2019	60.98K	Sale	Scheduled	Mar 27
Form 4	-5.56%	-3.60K	$88.05	-$316.80K	Mar 26, 2019	61.08K	Tax	—	Mar 22
Form 4	40.92%	25.59K	$94.53	-$683.17K	Mar 19, 2019	88.13K	Grant	—	Mar 15
Form 4	22.04%	11.29K	$94.76	-$86.42K	Mar 05, 2019	62.54K	Grant	—	Mar 01
Form 4	0.34%	175.00	$68.78	$12.04K	Dec 20, 2018	51.25K	Grant	—	Oct 31
Form 4	-16.37%	-10.00K	$99.00	-$990.00K	Jun 26, 2018	51.07K	Sale	Scheduled	Jun 22
Form 4	-2.47%	-1.54K	$80.43	-$146.05K	Jun 06, 2018	61.07K	Grant	—	Apr 30 - Jun 04
Form 4/A	-4.66%	-3.60K	$81.36	-$292.73K	Apr 27, 2018	73.59K	Tax	—	Mar 22
Form 4/A	21.90%	12.62K	—	—	Apr 26, 2018	70.22K	Grant	—	Feb 26
Form 4	-15.03%	-11.06K	$82.15	-$908.50K	Apr 25, 2018	62.54K	Sale	Scheduled	Apr 23
Form 4	-4.64%	-3.58K	$81.36	-$291.51K	Mar 26, 2018	73.60K	Tax	—	Mar 22
Form 4	70.88%	48.56K	$83.57	-$318.82K	Mar 19, 2018	117.09K	Grant	—	Mar 15
Form 4	-2.29%	-1.61K	$79.86	-$128.49K	Mar 06, 2018	68.52K	Tax	—	Mar 02
Form 4	21.75%	12.53K	—	—	Feb 28, 2018	70.13K	Grant	—	Feb 26
Form 4/A	-23.47%	-34.08K	$98.91	-$2.12M	Oct 13, 2017	111.14K	Sale	Scheduled	May 27
Form 4	-7.17%	-1.80K	$90.72	-$163.39K	Jun 06, 2017	23.30K	Tax	—	Jun 02
Form 4	-5.88%	-1.57K	$80.90	-$146.67K	May 17, 2017	25.10K	Grant	—	Apr 28 - May 15
Form 4	357.13%	51.68K	—	—	Mar 24, 2017	66.15K	Grant	—	Mar 22
Form 4	-30.30%	-6.29K	$92.33	-$580.75K	Mar 17, 2017	14.47K	Sale	Scheduled	Mar 15 - Mar 16
Form 4	-9.99%	-2.30K	$93.32	-$214.92K	Mar 08, 2017	20.76K	Sale	Scheduled	Mar 06
Form 4	-9.01%	-2.28K	$93.95	-$214.49K	Mar 07, 2017	23.06K	Tax	—	Mar 03
Form 4	-42.66%	-35.00K	$78.58	-$1.40M	Mar 02, 2017	47.05K	Sale	Scheduled	Feb 28 - Mar 01
Form 4	67.66%	12.25K	—	—	Feb 28, 2017	30.35K	Grant	—	Feb 24
Form 4	-21.65%	-5.00K	$90.00	-$450.00K	Jan 10, 2017	18.10K	Sale	Scheduled	Jan 09
Form 4	-46.21%	-19.84K	$79.53	-$1.80M	Nov 14, 2016	23.10K	Sale	—	Oct 31 - Nov 09
Form 4	-8.52%	-4.00K	$99.33	-$397.32K	Aug 03, 2016	42.94K	Sale	Scheduled	Aug 01
Form 4	-3.39%	-1.65K	$89.14	-$146.99K	Jun 08, 2016	46.94K	Sale	Scheduled	Jun 06
Form 4/A	-86.65%	-16.90K	—	—	Jun 08, 2016	2.60K	Options	—	May 31
Form 4	-3.57%	-1.80K	$90.00	-$162.09K	Jun 07, 2016	48.59K	Tax	—	Jun 03
Form 4	32.34%	12.95K	$64.47	-$1.21M	Jun 02, 2016	53.00K	Sell-Options	Scheduled	May 31
Form 4	-7.34%	-4.30K	$89.09	-$383.53K	May 31, 2016	54.34K	Tax	—	May 27
Form 4	-6.04%	-3.77K	$87.07	-$328.18K	May 25, 2016	58.64K	Sale	Scheduled	May 23
Form 4	-2.38%	-1.52K	$66.99	-$132.07K	May 17, 2016	62.41K	Grant	—	Apr 29 - May 13
Form 4	114.03%	53.93K	—	—	Mar 17, 2016	101.22K	Grant	—	Mar 15
Form 4	-4.82%	-2.40K	$89.57	-$214.52K	Mar 07, 2016	47.29K	Tax	—	Mar 03
Form 4	-50.84%	-51.39K	$82.25	-$4.23M	Mar 02, 2016	49.69K	Sale	Scheduled	Feb 29 - Mar 02
Form 4	255.35%	72.63K	—	—	Feb 26, 2016	101.08K	Grant	—	Feb 24
Form 4	-29.53%	-20.00K	$71.68	-$1.30M	Nov 18, 2015	47.73K	Sale	Scheduled	Nov 16
Form 4	-10.89%	-3.45K	$121.34	-$418.62K	Jun 08, 2015	28.23K	Sale	Scheduled	Jun 04 - Jun 05
Form 4	-23.68%	-9.83K	$125.10	-$1.23M	Jun 03, 2015	31.68K	Sale	Scheduled	May 29 - Jun 01
Form 4	-45.09%	-34.08K	$130.00	-$4.43M	May 28, 2015	41.51K	Sale	Scheduled	May 18
Form 4	0.54%	425.00	$122.27	$49.99K	May 19, 2015	75.59K	Grant	Scheduled	Apr 30 - May 18
Form 4	50.02%	34.40K	—	—	Mar 05, 2015	103.18K	Grant	—	Mar 03
Form 4	-12.53%	-15.50K	$73.03	-$1.05M	Mar 04, 2015	108.18K	Sale	—	Mar 02
Form 4	0.08%	57.00	$67.63	$3.44K	Feb 10, 2015	68.73K	Grant	—	Mar 18 - Sep 03
Form 4	-11.46%	-16.00K	$54.45	-$492.35K	Sep 03, 2014	123.68K	Sale	—	Sep 02
Form 4	-3.14%	-2.23K	$61.76	-$137.65K	Aug 04, 2014	68.68K	Sale	—	Aug 01
Form 4	-3.05%	-2.23K	$64.00	-$142.66K	Jul 03, 2014	70.91K	Sale	—	Jul 02
Form 4	110.39%	65.50K	—	—	Jun 06, 2014	124.83K	Grant	—	Jun 04
Form 4	-6.01%	-3.79K	$57.50	-$218.04K	Jun 02, 2014	59.33K	Tax	—	May 29
Form 4	-1.78%	-1.15K	$53.47	-$66.63K	May 16, 2014	63.13K	Grant	—	Apr 30 - May 15
Form 4	-5.58%	-8.00K	$59.69	-$330.05K	Mar 05, 2014	135.27K	Sale	Scheduled	Mar 03
Form 4	69.04%	26.25K	—	—	Feb 19, 2014	64.27K	Grant	—	Feb 14
Form 4	-7.15%	-9.00K	$54.60	-$279.73K	Dec 04, 2013	116.95K	Sale	Scheduled	Dec 02
Form 4	-6.67%	-9.00K	$54.03	-$269.46K	Sep 05, 2013	125.95K	Sale	Scheduled	Sep 04
Form 4	-9.68%	-4.07K	$59.78	-$243.06K	Jul 02, 2013	37.95K	Sale	Scheduled	Jul 01
Form 4	-9.06%	-4.18K	$64.46	-$269.70K	May 30, 2013	42.02K	Tax	—	May 29
Form 4	-34.12%	-63.80K	—	—	May 17, 2013	123.20K	Grant	—	May 15
Form 4	-17.72%	-28.00K	$51.74	-$710.22K	May 03, 2013	130.00K	Sale	—	May 01
Form 4	—	158.00K	—	—	May 31, 2012	158.00K	Grant	—	May 29
Form 3	—	—	—	—	May 29, 2012	—	—	—	—

Showing 63 results

OMEROS CORP

Investor

Updated Jun 04, 2012

View Quote Details


Form 4	—	5.00K	—	—	Jun 04, 2012	5.00K	Grant	—	Jun 01
Form 4	—	5.00K	—	—	May 31, 2011	5.00K	Grant	—	May 27
Form 4	—	15.00K	—	—	Dec 09, 2009	15.00K	Grant	—	Dec 08
Form 3	—	—	—	—	Dec 09, 2009	—	—	—	—

Showing 4 results

MYRIAD GENETICS INC

Investor

Updated Jun 07, 2024

View Quote Details


Form 4	—	—	—	—	Jun 07, 2024	32.92K	—	—	—
Form 4	-18.71%	-7.58K	$22.05	-$167.01K	Jun 04, 2024	32.92K	Sale	Scheduled	Jun 03 - Jun 04
Form 4	19.17%	6.51K	$23.01	-$198.76K	Jun 02, 2023	40.49K	Grant	—	Jun 01 - Jun 02
Form 4	-15.90%	-6.42K	$19.25	-$123.67K	Jun 06, 2022	33.98K	Sale	Scheduled	Jun 06
Form 4	74.69%	17.27K	—	—	Jun 03, 2022	40.40K	Grant	—	Jun 02
Form 4	-11.95%	-3.14K	$30.52	-$95.79K	Jun 17, 2021	23.13K	Sale	Scheduled	Jun 17
Form 4	95.74%	12.85K	—	—	Jun 04, 2021	26.27K	Grant	—	Jun 03
Form 4	-34.73%	-7.14K	$28.99	-$207.02K	Jun 01, 2021	13.42K	Sale	Scheduled	May 28
Form 4	-43.59%	-15.89K	—	—	May 28, 2021	20.56K	Disposition	—	May 27
Form 4	77.27%	15.89K	—	—	Dec 07, 2020	36.45K	Grant	—	Dec 04
Form 4	—	20.56K	—	—	May 28, 2020	20.56K	Grant	—	May 27
Form 3	—	—	—	—	May 28, 2020	—	—	—	—

Showing 12 results

Cyclacel Pharmaceuticals, Inc.

Investor

Updated May 24, 2012

View Quote Details


Form 4	—	35.00K	—	—	May 24, 2012	35.00K	Grant	—	May 23
Form 4	—	35.00K	—	—	May 26, 2011	35.00K	Grant	—	May 24
Form 4	—	35.00K	—	—	Mar 31, 2010	35.00K	Grant	—	Mar 29
Form 4	—	35.00K	—	—	Mar 31, 2009	35.00K	Grant	—	Mar 27
Form 4	—	25.00K	—	—	Feb 21, 2008	25.00K	Grant	—	Feb 19
Form 4	—	33.75K	—	—	Mar 13, 2007	33.75K	Grant	—	Mar 09
Form 4	0.10%	26.25	$6.40	$168.00	Jul 11, 2006	26.25K	Grant	—	Jun 14
Form 4	—	15.00K	—	—	Jun 17, 2005	15.00K	Grant	—	Jun 17
Form 4	—	10.00K	—	—	Sep 07, 2004	10.00K	Grant	—	Sep 02
Form 3	—	—	—	—	Sep 07, 2004	—	—	—	—

Showing 10 results

SPRUCE BIOSCIENCES, INC.

Investor

Updated May 24, 2024

View Quote Details


Form 4	—	30.00K	—	—	May 24, 2024	30.00K	Grant	—	May 22
Form 4	—	30.00K	—	—	May 26, 2023	30.00K	Grant	—	May 25
Form 4	—	22.50K	—	—	May 27, 2022	22.50K	Grant	—	May 25
Form 4	—	6.67K	—	—	May 21, 2021	6.67K	Grant	—	May 20
Form 3	—	—	—	—	Oct 08, 2020	—	—	—	—

Showing 5 results

Jiya Acquisition Corp.

Investor

Updated Nov 18, 2020


Form 3	—	—	—	—	Nov 18, 2020	—	—	—	—

Showing 1 results

AFFYMAX INC

Investor

Updated Jun 18, 2012


Form 4	—	12.00K	—	—	Jun 18, 2012	12.00K	Grant	—	Jun 13
Form 4	—	12.00K	—	—	May 26, 2011	12.00K	Grant	—	May 25
Form 4	—	7.50K	—	—	May 26, 2010	7.50K	Grant	—	May 24
Form 4	—	2.50K	—	—	May 29, 2009	2.50K	Grant	—	May 28
Form 4	—	2.50K	—	—	May 23, 2008	2.50K	Grant	—	May 22
Form 4	—	2.50K	—	—	May 31, 2007	2.50K	Grant	—	May 31
Form 3	—	—	—	—	Dec 14, 2006	—	—	—	—

Showing 7 results

Anthera Pharmaceuticals Inc

Investor

Updated Feb 23, 2010


Form 3	—	—	—	—	Feb 23, 2010	—	—	—	—

Showing 1 results

CV THERAPEUTICS INC

SVP, CFO

Updated Apr 17, 2009


Form 4	-100.00%	-88.54K	$9.55	-$845.58K	Apr 17, 2009	74.46K	Options	—	Apr 16
Form 4	-8.10%	-5.95K	$19.94	-$118.64K	Apr 09, 2009	74.16K	Tax	—	Apr 09
Form 4	-46.54%	-141.03K	$15.83	-$586.83K	Apr 03, 2009	168.65K	Sale	—	Apr 02
Form 4	-4.14%	-4.32K	$15.58	$127.48K	Feb 26, 2009	106.57K	Options	—	Feb 25
Form 4	-5.90%	-1.79K	$8.48	$27.25K	Dec 15, 2008	33.51K	Options	—	Dec 11
Form 4	-4.82%	-1.79K	$9.51	$30.56K	Dec 10, 2008	40.25K	Options	—	Dec 09
Form 4	-2.87%	-2.00K	$6.95	$18.65K	Feb 27, 2008	72.76K	Options	—	Feb 26
Form 4	1,345.29%	6.00K	$10.00	$60.00K	Dec 21, 2007	9.73K	s	Scheduled	Dec 21
Form 4	-6.11%	-1.79K	$9.40	$30.20K	Dec 13, 2007	30.73K	Grant	—	Dec 11
Form 4	-46.42%	-8.00K	$10.03	-$80.24K	Dec 11, 2007	12.52K	Sale	Scheduled	Dec 10
Form 4	-6.16%	-1.79K	$9.50	$30.52K	Dec 07, 2007	30.52K	Grant	—	Dec 05
Form 4	-24.17%	-4.47K	$10.12	$81.28K	Nov 13, 2007	17.30K	Grant	—	Nov 09
Form 4	—	250.00K	—	—	Aug 24, 2007	250.00K	Grant	—	Aug 22
Form 4	—	—	—	—	Feb 26, 2007	8.16K	—	—	—
Form 4	-62.79%	-7.40K	$13.93	-$97.51K	Jan 18, 2007	7.67K	Sale	Scheduled	Dec 22 - Jan 17
Form 4	-6.63%	-4.38K	$13.81	-$60.56K	Jan 05, 2007	61.79K	Options	—	Jan 03
Form 4	496.97%	32.00K	$12.92	-$38.76K	Dec 13, 2006	38.44K	Grant	Scheduled	Dec 11 - Dec 12
Form 4	-7.69%	-1.79K	$12.84	-$22.95K	Dec 07, 2006	23.58K	Options	—	Dec 05
Form 4	-0.09%	-51.00	$24.76	-$1.26K	Jan 05, 2006	59.00K	Options	—	Jan 03
Form 4	—	35.00K	—	—	Dec 07, 2005	37.68K	Grant	—	Dec 05
Form 4	-50.00%	-26.50K	$13.15	-$668.06K	Nov 04, 2005	28.36K	Sale	—	Nov 03
Form 4	-92.04%	-21.50K	$22.78	-$557.83K	Aug 30, 2005	23.69K	Sale	—	Jan 24 - Aug 26
Form 4	—	100.00K	—	—	Jan 05, 2005	100.00K	Grant	—	Jan 03
Form 4	9.76%	2.00K	$9.00	$9.00K	Dec 29, 2004	24.01K	Options	—	Dec 28
Form 4	-25.01%	-7.50K	$16.43	-$111.45K	Dec 20, 2004	44.00K	Sale	—	Dec 16
Form 4	80.93%	681.66	$14.67	$10.00K	Apr 08, 2004	21.34K	Grant	—	Jan 13
Form 4	-0.97%	-200.00	—	—	Dec 19, 2003	21.32K	Grant	—	Dec 16
Form 4	—	75.00K	—	—	Dec 12, 2003	75.00K	Grant	—	Dec 11
Form 4	—	—	—	—	Jul 24, 2003	—	—	—	—
Form 4	—	—	—	—	Jun 27, 2003	—	—	—	—

Showing 30 results

Kyverna Therapeutics, Inc.

Investor

Updated Feb 07, 2024


Form 3	—	—	—	—	Feb 07, 2024	—	—	—	—

Showing 1 results

vTv Therapeutics Inc.

Investor

Updated Jun 27, 2024

View Quote Details


Form 4	—	6.00K	$17.22	$103.32K	Jun 27, 2024	6.00K	Grant	—	Jun 25
Form 3	—	—	—	—	Jun 13, 2024	—	—	—	—

Showing 2 results